Your proposal is definitely less bad than the current system, but it still assumes innovation needs a government referee deciding who gets exclusivity, for how long, and when taxpayers should compensate private research.
That’s the part I can’t get behind.
If the product is not commercially viable without monopoly protection or public reimbursement, maybe the business model is the issue. And if the government reimburses the company, that just means society absorbs the risk while the company keeps the upside.
Who decides the reimbursement amount? Who pays for failed research? Taxpayers? Competing companies? Consumers?
Private companies should be rewarded by the market when they create value, not guaranteed protection from competition and then reimbursed when the state decides the invention is important.
Shorter patents reduce the damage, but they don’t remove the contradiction: a “limited monopoly” is still a monopoly.




That’s kind of my point.
If a system keeps getting abused to grant monopolies on absurdly broad concepts, maybe the problem isn’t just bad decisions, maybe the incentives themselves are broken.
And in practice, litigation costs alone already scare away competitors long before courts decide anything.